Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
National University Hospital (Singapore) Pte. Ltd. maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area with 4 pending office actions. These actions are distributed among 4 distinct examiners, which indicates that each pending matter is being handled by a different individual. This distribution suggests a variety of perspectives are currently being applied to the company's biotechnology filings. The use of multiple examiners can often lead to different prosecution timelines and outcomes even within the same broad technology area.
The prosecution activity spans 3 distinct art units, showing that the portfolio covers several specialized sub-sectors within the broader Biotechnology & Pharmaceuticals field. The busiest examiner is YU, HONG, who is responsible for 1 pending office action. Since the busiest examiner only handles a single action, the portfolio's prosecution risk is well-diversified across different examiners and 3 art units rather than being concentrated under a single reviewer. This diversification may provide the company with more opportunities to secure patent protection through different examination channels simultaneously.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, HONG | 1 | 30.9% | +5.6% |
| FLORES, ADRIAN | 1 | 100.0% | +0.0% |
| SISSON, BRADLEY L | 1 | 19.7% | +20.5% |
| AMAR, MARC J | 1 | 75.1% | +37.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553197 | VENOUS CANNULAS WITH INFLATABLE BALLOONS | AMAR, MARC J | 70d |
| 18709643 | INHALABLE RECOMBINANT PROTEIN POWDER FORMULATION FOR TREATING GENETIC AND AUTOIMMUNE DISORDERS | YU, HONG | — |
| 18693526 | A SURGICAL TRICUSPID VALVE PROSTHESIS | FLORES, ADRIAN | — |
| 18294652 | A METHOD OF DETECTING A THYROID BIOMARKER | SISSON, BRADLEY L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553197 | VENOUS CANNULAS WITH INFLATABLE BALLOONS | AMAR, MARC J | 70d |
| 18294652 | A METHOD OF DETECTING A THYROID BIOMARKER | SISSON, BRADLEY L | — |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1682 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18709643 | INHALABLE RECOMBINANT PROTEIN POWDER FORMULATION FOR TREATING GENETIC AND AUTOIMMUNE DISORDERS | YU, HONG | 1614 | §103§112Other | Non-Final OA | — | Pending | May 13, 2024 |
| 18693526 | A SURGICAL TRICUSPID VALVE PROSTHESIS | FLORES, ADRIAN | — | §103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18294652 | A METHOD OF DETECTING A THYROID BIOMARKER | SISSON, BRADLEY L | 1682 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18553197 | VENOUS CANNULAS WITH INFLATABLE BALLOONS | AMAR, MARC J | 3741 | §102§103§112 | Non-Final OA | 70d | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial